Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
A Multidisciplinary Approach to Impact Acute Care Utilization in Sickle Cell Disease
source: American Journal of Medical Quality
year: 2017
authors: Rhea E. Powell, MD, MPH, Paris B. Lovett, MD, MBA, Albert Crawford, PhD, MBA, MSIS, John McAna, PhD, David Axelrod, MD, Lawrence Ward, MD, MPH, Dianne Pulte, MD
summary/abstract:Sickle cell disease (SCD), an inherited red blood cell disorder, is characterized by anemia, end-organ damage, unpredictable episodes of pain, and early mortality. Emergency department (ED) visits and hospitalizations are frequent, leading to increased burden on patients and increased health care costs. This study assessed the effects of a multidisciplinary care team intervention on acute care utilization among adults with SCD. The multidisciplinary care team intervention included monthly team meetings and development of individualized care plans. Individualized care plans included targeted pain management plans for management of uncomplicated pain crisis. Following implementation of the multidisciplinary care team intervention, a significant decrease in ED utilization was identified among those individuals with a history of high ED utilization. Findings highlight the potential strength of multidisciplinary interventions and suggest that targeting interventions toward high-utilizing subpopulations may offer the greatest impact.
organization: Thomas Jefferson University, Philadelphia; EMCare, Inc., Dallas; German Cancer Research CenterDOI: 10.1177/1062860617707262
read more full text
+myBinderRelated Content
-
Sophie Lanzkron, MD, MHSDr. Sophie Lanzkron is an associate prof...
-
Russell Ware, MD, PhDRussell Ware, MD, PhD, has been involved...
-
Emergency Guide: When to see the doctorIt is very important that every person o...
-
My medical school lesson was tinged with racism. Did that affect how I treated a sickle cell patient years later?The young woman was curled up in a ball....
-
Gene-Therapy Company Crispr Drops as FDA Puts Trial on HoldCrispr Therapeutics AG plunged after the...
-
Wake Forest University Sickle Cell Center of ExcellenceWake Forest School of Medicine has serve...
-
Pfizer rare disease introduces Council for Change to further help SCD patientsFollowing a report earlier thi...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.